Plaintiffs File Motion to Consolidate All Federal Lawsuits Linking AndroGel Testosterone Therapy to Heart Attacks, Strokes



DOCUMENTS
  • Brief in Support of Transfer


WASHINGTON, D.C. — Plaintiffs in more than a dozen federal lawsuits accusing Abbott Laboratories and AbbVie Inc. of concealing cardiovascular risks associated with the testosterone replacement therapy AndroGel have filed a petition to have all similar cases around the country transferred to Illinois.

In a brief submitted March 28, lawyers for plaintiffs in 13 of the 38 cases pending in Illinois, Pennsylvania and Colorado asked the Judicial Panel on Multidistrict Litigation (JPML) to create a docket in U.S. District Court for centralized management of the federal lawsuits. They say the creation of a multi-district litigation (MDL) docket is necessary because …

FIRM NAMES
  • Schachter, Hendy & Johnson
  • The Lyon Firm





UPCOMING CONFERENCES




HarrisMartin's Ozempic MDL Conference: Updates from the Status Hearing

March 15, 2024 - Philadelphia, PA
Kimpton Hotel Monaco Philadelphia

MORE DETAILS



HarrisMartin's New Jersey Asbestos Litigation Conference

March 01, 2024 - New Brunswick, NJ
Hyatt Regency New Brunswick

MORE DETAILS